Indian Journal of Respiratory Care

Register      Login

VOLUME 11 , ISSUE 4 ( October-December, 2022 ) > List of Articles

REVIEW ARTICLE

A Comprehensive Review on the Management of ARDS among Pediatric Patients

Anil Kumar Sapare, Yashwanth Raju Hunasagahalli Nagaraju

Keywords : Pediatric acute respiratory distress syndrome, population, positive end-expiratory pressure, ventilation

Citation Information : Sapare AK, Nagaraju YR. A Comprehensive Review on the Management of ARDS among Pediatric Patients. Indian J Respir Care 2022; 11 (4):296-301.

DOI: 10.4103/ijrc.ijrc_158_22

License: CC BY-NC-SA 4.0

Published Online: 01-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Pediatric acute respiratory distress syndrome (PARDS) is a complex inflammatory syndrome of lungs leading to disruption of alveolar epithelial membrane barrier in the lungs. It includes varying age groups from infants to adolescents. PARDS definition has changed over decades as current definition is given by the Pediatric Acute Lung Injury Consensus Conference group. Although most of management principles are extrapolated from adult data, physiology of Acute Respiratory Distress Syndrome (ARDS) in children is different when compared to adults. The present review mainly focused on current evidence in the management of ARDS with emphasis to pediatric population. MeSH headings such as ARDS, positive end-expiratory pressure (PEEP), and lung protective ventilation were used for searching publications in PubMed, Embase, and SciELO. Publications were limited to human studies in the past 20 years. Core ventilatory strategies in PARDS include use of low-tidal volume, higher PEEP and acceptance of permissive hypercapnia and permissive hypoxemia. Supportive strategies such as restrictive fluid therapy, prone positioning, early enteral nutrition, and adequate analgosedation remain the mainstay of management of principles. As PARDS contains heterogeneous population, personalized mechanical ventilation under umbrella of lung protective ventilator strategies such as low-tidal volume ventilation, open lung strategy, acceptance of permissive hypercapnia, and permissive hypoxia is standard of care.


PDF Share
  1. Swenson KE, Swenson ER. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury. Crit Care Clin 2021;37:749-76.
  2. Heidemann SM, Nair A, Bulut Y, Sapru A. Pathophysiology and management of acute respiratory distress syndrome in children. Pediatr Clin North Am 2017;64:1017-37.
  3. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23.
  4. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
  5. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
  6. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: The berlin definition. JAMA 2012;307:2526-33.
  7. Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: Consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med 2015;16:428-39.
  8. De Troyer A, Boriek AM. Mechanics of the respiratory muscles. Compr Physiol 2011;1:1273-300.
  9. Zeng JS, Qian SY, Wong JJ, Ong JS, Gan CS, Anantasit N, et al. Non.invasive ventilation in children with paediatric acute respiratory distress syndrome. Ann Acad Med Singap 2019;48:224.32.
  10. Kopp W, Gedeit RG, Asaro LA, McLaughlin GE, Wypij D, Curley MA, et al. The impact of preintubation noninvasive ventilation on outcomes in pediatric acute respiratory distress syndrome. Crit Care Med 2021;49:816.27.
  11. Gattinoni L, Pesenti A. The concept of “baby lung”. Intensive Care Med 2005;31:776.84.
  12. Main E, Castle R, Stocks J, James I, Hatch D. The influence of endotracheal tube leak on the assessment of respiratory function in ventilated children. Intensive Care Med 2001;27:1788.97.
  13. Kıhtır HS, Akçay N, Şevketoğlu Pressure.regulated volume control and pressure.control ventilation modes in pediatric acute respiratory failure. Turk J Anaesthesiol Reanim 2022;50:18.23.
  14. Duyndam A, Ista E, Houmes RJ, van Driel B, Reiss I, Tibboel D. Invasive ventilation modes in children: A systematic review and meta.analysis. Crit Care 2011;15:R24.
  15. Writing Group for the PReVENT Investigators, Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, et al. Effect of a low versus intermediate tidal volume strategy on ventilator.free days in intensive care unit patients without ARDS: A randomized clinical trial. JAMA 2018;320:1872.80.
  16. Rauf A, Sachdev A, Venkataraman ST, Dinand V. Dynamic airway driving pressure and outcomes in children with acute hypoxemic respiratory failure. Respir Care 2021;66:403.9.
  17. Khemani RG, Parvathaneni K, Yehya N, Bhalla AK, Thomas NJ, Newth CJ. Positive end.expiratory pressure lower than the ARDS network protocol is associated with higher pediatric acute respiratory distress syndrome mortality. Am J Respir Crit Care Med 2018;198:77.89.
  18. Abdelsalam M. Permissive hypoxemia: Is it time to change our approach? Chest 2006;129:210.1.
  19. Bigatello LM, Patroniti N, Sangalli F. Permissive hypercapnia. Curr Opin Crit Care 2001;7:34.40.
  20. Hubmayr RD, Kallet RH. Understanding pulmonary stress.strain relationships in severe ARDS and its implications for designing a safer approach to setting the ventilator. Respir Care 2018;63:219.26.
  21. Coppola S, Caccioppola A, Froio S, Formenti P, De Giorgis V, Galanti V, et al. Effect of mechanical power on intensive care mortality in ARDS patients. Crit Care 2020;24:246.
  22. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301.8.
  23. Mireles-Cabodevila E, Dugar S, Chatburn RL. APRV for ARDS: The complexities of a mode and how it affects even the best trials. J Thorac Dis 2018;10:S1058.63.
  24. Hering R, Zinserling J, Wrigge H, Varelmann D, Berg A, Kreyer S, et al. Effects of spontaneous breathing during airway pressure release ventilation on respiratory work and muscle blood flow in experimental lung injury. Chest 2005;128:2991.8.
  25. Junqueira FM, Nadal JA, Brandao MB, Nogueira RJ, de Souza TH. High.frequency oscillatory ventilation in children: A systematic review and meta.analysis. Pediatr Pulmonol 2021;56:1872.88.
  26. Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R, et al. High.frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013;368:806.13.
  27. Pelosi P, Ball L, Barbas CS, Bellomo R, Burns KE, Einav S, et al. Personalized mechanical ventilation in acute respiratory distress syndrome. Crit Care 2021;25:250.
  28. Battaglini D, Sottano M, Ball L, Robba C, Rocco PR, Pelosi P. Ten golden rules for individualized mechanical ventilation in acute respiratory distress syndrome. J Intensive Med 2021;1:42.51.
  29. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 2017;195:331.8.
  30. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet 1996;348:75.82.
  31. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009;374:1351.63.
  32. Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159.68.
  33. Guerin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, et al. A prospective international observational prevalence study on prone positioning of ARDS patients: The APRONET (ARDS prone position network) study. Intensive Care Med 2018;44:22.37.
  34. PROSpect: prone and oscillation pediatric clinical trial. Available online: https://clinicaltrials.gov/ct2/show/NCT03896763. [Last accessed on 2022 Oct 11].
  35. Treschan TA, Beiderlinden M. Role of recruitment maneuvers for lung.protective ventilation in the operating room remains unclear. Anesthesiology 2015;122:472.3.
  36. Suzumura EA, Figueiro M, Normilio-Silva K, Laranjeira L, Oliveira C, Buehler AM, et al. Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome: A systematic review and meta.analysis. Intensive Care Med 2014;40:1227.40.
  37. Hodgson CL, Cooper DJ, Arabi Y, King V, Bersten A, Bihari S, et al. Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial. Am J Respir Crit Care Med 2019;200:1363.72.
  38. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038.47.
  39. Gunther A, Ruppert C, Schmidt R, Markart P, Grimminger F, Walmrath D, et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001;2:353.64.
  40. Tamburro RF, Kneyber MC, Pediatric Acute Lung Injury Consensus Conference Group. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: Proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med 2015;16:S61.72.
  41. Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJ, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018;46:e825.73.
  42. Deeter KH, King MA, Ridling D, Irby GL, Lynn AM, Zimmerman JJ. Successful implementation of a pediatric sedation protocol for mechanically ventilated patients. Crit Care Med 2011;39:683.8.
  43. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine versus lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007;298:2644.53.
  44. Randolph AG, Forbes PW, Gedeit RG, Arnold JH, Wetzel RC, Luckett PM, et al. Cumulative fluid intake minus output is not associated with ventilator weaning duration or extubation outcomes in children. Pediatr Crit Care Med 2005;6:642.7.
  45. Avila-Diaz M, Ventura MD, Valle D, Vicente-Martinez M, Garcia-Gonzalez Z, Cisneros A, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 2006;26:574.80.
  46. Grissom CK, Hirshberg EL, Dickerson JB, Brown SM, Lanspa MJ, Liu KD, et al. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*. Crit Care Med 2015;43:288.95.
  47. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, et al. Comparison of two fluid.management strategies in acute lung injury. N Engl J Med 2006;354:2564.75.
  48. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids. New mechanisms for old drugs. N Engl J Med 2005;353:1711.23.
  49. Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG. Cytokines and biotrauma in ventilator.induced lung injury: A critical review of the literature. Neth J Med 2005;63:382.92.
  50. Hartmann SM, Hough CL. Argument against the routine use of steroids for pediatric acute respiratory distress syndrome. Front Pediatr 2016;4:79.
  51. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: Evidence for inadequate endogenous glucocorticoid secretion and inflammation.induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002;165:983.91.
  52. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007;131:954.63.
  53. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: Rationale for prolonged glucocorticoid therapy. Chest 2009;136:1631.43.
  54. Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir Med 2020;8:267.76.
  55. Barbosa MC, Barbosa AP, Rocco PR. Corticosteroids therapy in pediatric acute respiratory distress syndrome. Rev Bras Ter Intensiva 2010;22:384.94.
  56. Wong JJ, Han WM, Sultana R, Loh TF, Lee JH. Nutrition delivery affects outcomes in pediatric acute respiratory distress syndrome. JPEN J Parenter Enteral Nutr 2017;41:1007.13.
  57. Sodhi CP, Jia H, Yamaguchi Y, Lu P, Good M, Egan C, et al. Intestinal epithelial TLR.4 activation is required for the development of acute lung injury after trauma/hemorrhagic shock via the release of HMGB1 from the gut. J Immunol 2015;194:4931.9.
  58. Briassoulis G, Filippou O, Kanariou M, Hatzis T. Comparative effects of early randomized immune or non.immune.enhancing enteral nutrition on cytokine production in children with septic shock. Intensive Care Med 2005;31:851.8.
  59. Ji M, Chen T, Wang B, Chen M, Ding Q, Chen L, et al. Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS. Exp Ther Med 2018;15:4665.70.
  60. Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med 2015;3:24.32.
  61. Christie JD, Vaslef S, Chang PK, May AK, Gunn SR, Yang S, et al. A Randomized dose.escalation study of the safety and anti.inflammatory activity of the p38 mitogen.activated protein kinase inhibitor dilmapimod in severe trauma subjects at risk for acute respiratory distress syndrome. Crit Care Med 2015;43:1859.69.
  62. Krenn K, Lucas R, Croize A, Boehme S, Klein KU, Hermann R, et al. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: A phase IIa randomized placebo.controlled trial. Crit Care 2017;21:194.
  63. Li Y, Li H, Liu S, Pan P, Su X, Tan H, et al. Pirfenidone ameliorates lipopolysaccharide.induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Mol Immunol 2018;99:134.44.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.